EPICS Therapeutics
PrivateLast Round
Early Funding
Sep 22, 2025
Total Funding Raised
$37.32M
Momentum Score
25 /100
Company Overview
EPICS Therapeutics is a drug discovery and development company that invents and develops small molecule drugs targeting ribonucleic acid (RNA) epigenetic mechanisms for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EPICS Therapeutics Comps
Public and private peers based on sector, stage, and business model.
EPICS Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Sep 22, 2025 | ||||
| Series A Extension | Oct 18, 2024 | ||||
| Series A | Dec 21, 2018 | ||||
| Seed | May 24, 2018 |
EPICS Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Early Funding |
| Fund+ | Early Funding, Series A, Series A Extension |
| Société Régionale d'Investissement de Wallonie | Seed, Series A |
| Investsud | Seed |
| Wallonie Entreprendre | Early Funding, Series A Extension |
| Theodorus | Seed |
| BNP Paribas Fortis Private Equity | Early Funding, Series A, Series A Extension |
EPICS Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EPICS Therapeutics's valuation, stock price, and market status.
